Adrian Burton. Show Affiliations »
Abstract
Mesh: See more » Drug ApprovalEnfuvirtideHIV Envelope Protein gp41/therapeutic useHIV Fusion Inhibitors/therapeutic useHIV Infections/drug therapyHIV-1/drug effectsHumansPeptide Fragments/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances: See more » HIV Envelope Protein gp41HIV Fusion InhibitorsPeptide FragmentsEnfuvirtide
Year: 2003 PMID: 12726955 DOI: 10.1016/s1473-3099(03)00620-0
Source DB: PubMed Journal: Lancet Infect Dis ISSN: 1473-3099 Impact factor: 25.071